Experienced in Ovarian Hyperstimulation Syndrome

Yvonne L. Giwercman

Malmoe, M, SE 
Experienced in Ovarian Hyperstimulation Syndrome
Malmoe, M, SE 
OverviewLocationsClinical Research

Overview

Yvonne Giwercman practices in Malmoe, Sweden. Ms. Giwercman is rated as an Experienced expert by MediFind in the treatment of Ovarian Hyperstimulation Syndrome. Her top areas of expertise are Isolated Hypogonadotropic Hypogonadism, Hypogonadotropic Hypogonadism, Hypogonadism, and Testicular Cancer.

Her clinical research consists of co-authoring 25 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Ovarian Hyperstimulation Syndrome.

Gender
Female

Locations

Malmoe, M, Sweden
Other Locations
Lund, M, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Clinical Study on Pharmacogenetics of Gonadotropin Receptors in Relation to Pregnancy and Life Birth Rate as Well as Unwanted Side Effects Such as Ovarian Hyper Stimulation Syndrome During Assisted Reproduction.
Clinical Study on Pharmacogenetics of Gonadotropin Receptors in Relation to Pregnancy and Life Birth Rate as Well as Unwanted Side Effects Such as Ovarian Hyper Stimulation Syndrome During Assisted Reproduction.
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug
Study Drugs: Follitropin Alpha, Menotropin
Study Phase: Not Applicable
Case Control Study Regarding the Role of Follicle Stimulating Hormone in Chemically Castrated Young Men
Case Control Study Regarding the Role of Follicle Stimulating Hormone in Chemically Castrated Young Men
Enrollment Status: Completed
Publish Date: January 22, 2020
Intervention Type: Drug
Study Phase: Not Applicable
View 1 Less Clinical Trial

25 Total Publications

FSH receptor N680S genotype-guided gonadotropin choice increases cumulative pregnancy and live birth rates after in vitro fertilization.
FSH receptor N680S genotype-guided gonadotropin choice increases cumulative pregnancy and live birth rates after in vitro fertilization.
Journal: Frontiers in endocrinology
Published: February 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Giwercman's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile